IPO · Commerce & Consumer Brands
Milky Mist plans ₹2,035 crore IPO in 2026
By Startup Enthusiast ·

- Date
- Company
- Milky Mist
- What it does
- Premium dairy products company
- Kind
- IPO
- Amount
- ₹2,035 crore
What they do
Milky Mist makes premium dairy products like Greek yoghurt and protein cheese
What happened
It plans a ₹2,035 crore IPO in 2026 after regulatory approval in October 2025
Why it matters
The company expects ~30% annual revenue growth and competes with Hatsun Agro and Heritage Foods
The details
- Milky Mist plans to proceed with its ₹2,035 crore IPO in 2026.
- The company received regulatory approval for the IPO in October 2025.
- The CEO expects ~30% annual revenue growth for the fiscal year ending 31 March and beyond.
- The company focuses on premium dairy: Greek yoghurt, protein-enriched cottage cheese, and high-protein milk.
- CEO Rathnam says India is protein-deficient and protein will be a major factor.
- Milky Mist competes with Hatsun Agro and Heritage Foods.
- Products are available across 350,000+ retail outlets as of March 2025.
- The company aims for 15-20% annual growth in store coverage.
The bigger picture
- Quick-commerce platforms are expected to contribute 12-15% of revenue in 3 years, from ~10% currently.
- Exports account for ~4% of revenue in fiscal 2025.
- The company expects US sales to rise in 1-2 years after an India-US trade deal.
About the business
- Milky Mist is India's fastest-growing packaged food company with 400+ products.
- New products include Sugar Free Ice Cream, Milk Shakes, Chocolate Condensed Milk, and Greek Yogurt varieties.
- It has a milk procurement network across Tamil Nadu with ties to local dairy farmers.
- The company operates 24 MW solar plants and a 2 MW wind farm in Tamil Nadu.
What happens next
- Aim for 15-20% annual growth in store coverage.
- Expect US sales to rise in 1-2 years after an India-US trade deal.
The deal
- Type
- ipo
Founders
- Sathishkumar T, founder
- Anitha S, founder
Same day
- DailyObjects crosses ₹320 crore annual run rate27 February 2026 · Results
- Zenex buys majority stake in VievePharm27 February 2026 · Acquisition
- Ferns N Petals revenue rises 22% in FY2527 February 2026 · Results
- Glovatrix builds sign language translation device27 February 2026 · Milestone · ₹1.7 crore
- Mygate narrows loss, achieves EBITDA breakeven in FY2527 February 2026 · Results
- Lenskart stock hits new high following robust quarterly results27 February 2026 · Results